Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pal Saetrom

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
New Biotechnology|March 12, 2010
MicroRNAs--targeting and target predictionTakaya Saito, Pal Saetrom
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2017
Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver CancerJon Voutila, Vikash Reebye, Thomas C Roberts, et al.
Oncogene|March 8, 2018
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancerVikash Reebye, Kai-Wen Huang, Vivian Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2020
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I TrialDebashis Sarker, Ruth Plummer, Tim Meyer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
New Biotechnology|March 12, 2010
MicroRNAs--targeting and target predictionTakaya Saito, Pal Saetrom
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2017
Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver CancerJon Voutila, Vikash Reebye, Thomas C Roberts, et al.
Oncogene|March 8, 2018
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancerVikash Reebye, Kai-Wen Huang, Vivian Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2020
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I TrialDebashis Sarker, Ruth Plummer, Tim Meyer, et al.
Pageof 1